2023-07-28 08:29:42 ET
- Fluor ( NYSE: FLR ) has been awarded a $487M biotech expansion project in Denmark and is also mobilizing resources in the central U.S. for the first phase of a new life sciences production facility valued at $574M.
- Fluor will recognize these reimbursable contracts in the second quarter backlog.
- “We are excited to see the significant investments being made globally in the production of cutting-edge technologies and pharmaceuticals that will improve the lives of billions of people,” said Richard Meserole, President of Fluor’s Advanced Technologies & Life Sciences business.
For further details see:
Fluor awarded contracts of over $1B